Grantham, Mayo, Van Otterloo & Co (GMO)
CNXC icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Concentrix CNXC Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CNXC Stock Details CNXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-39,532
Closed -$1.08M – 674
2026
Q1 		$1.08M Sell
39,532
-752
-2% -$26.7K ﹤0.01% 498
2025
Q4 		$1.68M Sell
40,284
-964
-2% -$39.1K ﹤0.01% 422
2025
Q3 		$1.9M Sell
41,248
-711
-2% -$37.9K 0.01% 378
2025
Q2 		$2.22M Buy
41,959
+16,825
+67% +$889K 0.01% 366
2025
Q1 		$1.4M Buy
25,134
+2,782
+12% +$133K ﹤0.01% 402
2024
Q4 		$967K Buy
22,352
+1,477
+7% +$65.7K ﹤0.01% 458
2024
Q3 		$1.07M Buy
+20,875
New +$1.4M ﹤0.01% 446
2021
Q3 		– Sell
-2,654
Closed -$427K – 693
2021
Q2 		$427K Sell
2,654
-300
-10% -$46.2K ﹤0.01% 634
2021
Q1 		$442K Buy
+2,954
New +$358K ﹤0.01% 723

Other funds holding CNXC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
KGI
Kopernik Global Investors Tampa, Florida $1.63B AUM 27.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
GBL
Groupe Bruxelles Lambert Brussels, Belgium $62.2M AUM 57.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CNXC Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Concentrix (CNXC) in Q2 2026, closing a stake of 39,532 shares — an estimated $1.08M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CNXC in Q1 2021 and held it in 9 quarters. The position peaked at $2.22M in Q2 2025. 271 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Concentrix position as of Q2 2026 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 39,532 Concentrix shares in Q2 2026, an estimated $1.08M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Concentrix in Q1 2021 and held it in 9 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Concentrix position peaked at $2.22M in Q2 2025.
  • 271 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.